Skip to main content
Equibles
SSKN logo

SSKN · STRATA Skin Sciences, Inc.

Track SSKN — free

Use SSKN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SSKN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.00 +0.00 (+0.00%) At close · Aug 14
Going-concern doubt — flagged Mar 26, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our history of operating losses and current default on our long-term debt raise substantial doubt regarding our ability to continue as a going concern.”
View the 10-K filed Mar 26, 2026
Market Cap
$588
Shares
5.89M

STRATA Skin Sciences, Inc. Earnings Call Transcripts

Every quarterly earnings call for STRATA Skin Sciences, Inc. (SSKN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲34.8% $9.06M −$849,000 '21 Q4 22-01-10 ▲20.8% $7.04M −$2.50M '22 Q1 22-05-11 ▲23.3% $9.11M −$1.89M '22 Q2 22-08-10 ▲22.1% $9.41M −$995,000 '22 Q3 22-11-09 ▲17.1% $10.60M −$160,000 '22 Q4 23-02-01 ▲7.5% $7.57M −$2.83M '23 Q1 23-04-12 ▼9.4% $8.25M −$3.15M '23 Q2 23-08-09 ▼6% $8.85M −$1.05M '23 Q3 23-11-15 ▼18% $8.69M −$3.79M '23 Q4 24-03-27 ▼10.7% $6.75M −$3.37M '24 Q1 24-05-15 ▲2.2% $8.44M −$91,000 '24 Q2 24-07-11 ▼0.6% $8.80M −$2.07M '24 Q3 24-11-13 ▲10.2% $9.58M −$4.55M '24 Q4 25-05-14 ▲0.9% $6.81M −$2.12M '25 Q1 25-05-14 ▼9.2% $7.66M −$2.58M '25 Q2 25-08-13 LATEST ▼21.2% $6.93M −$1.62M '25 Q3 25-11-13
Earnings call
FY25 · Q3
2025-11-13
STRATA Skin Sciences, Inc. Q3 FY2025 Earnings Call
Positive tone Expanded CPT codes and reimbursement International expansion LaserOptik litigation
Revenue
$6.93M
▼ 21.2% YoY
Diluted EPS
$-0.36
Gross margin
60.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
STRATA Skin Sciences, Inc. Q2 FY2025 Earnings Call
Confident tone XTRAC installed base and utilization CPT code expansion and reimbursement International revenue and tariffs
Revenue
$7.66M
▼ 9.2% YoY
Diluted EPS
$-0.62
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
STRATA Skin Sciences, Inc. Q1 FY2025 Earnings Call
Confident tone TheraClearX device growth XTRAC recurring revenue and per-device utilization Elevate 360 consulting program
Revenue
$6.81M
▲ 0.9% YoY
Diluted EPS
$-0.51
Gross margin
53.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-05-14
STRATA Skin Sciences, Inc. Q4 FY2024 Earnings Call
Revenue
$9.58M*
▲ 10.2% YoY
Gross margin
61.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
STRATA Skin Sciences, Inc. Q3 FY2024 Earnings Call
Positive tone New York sales tax audit Gross margin and cost discipline XTRAC device performance
Revenue
$8.80M
▼ 0.6% YoY
Diluted EPS
$-0.51
Gross margin
60.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-11
STRATA Skin Sciences, Inc. Q2 FY2024 Earnings Call
Positive tone International / Japan Expansion XTRAC Installed Base Optimization DTC Marketing Expansion
Revenue
$8.44M
▲ 2.2% YoY
Diluted EPS
$-0.03
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
STRATA Skin Sciences, Inc. Q1 FY2024 Earnings Call
Positive tone Direct-to-consumer marketing Utilization and tier management TheraClearX growth
Revenue
$6.75M
▼ 10.7% YoY
Diluted EPS
$-0.10
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
STRATA Skin Sciences, Inc. Q4 FY2023 Earnings Call
Positive tone XTRAC installed base and utilization DTC (direct-to-consumer) recurring revenue model TheraClearX launch and reimbursement
Revenue
$8.69M*
▼ 18% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
STRATA Skin Sciences, Inc. Q3 FY2023 Earnings Call
Revenue
$8.85M
▼ 6% YoY
Diluted EPS
$-0.30
Gross margin
56.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
STRATA Skin Sciences, Inc. Q2 FY2023 Earnings Call
Revenue
$8.25M
▼ 9.4% YoY
Diluted EPS
$-0.90
Gross margin
52.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-12
STRATA Skin Sciences, Inc. Q1 FY2023 Earnings Call
Revenue
$7.57M
▲ 7.5% YoY
Diluted EPS
$-0.80
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-01
STRATA Skin Sciences, Inc. Q4 FY2022 Earnings Call
Revenue
$10.60M*
▲ 17.1% YoY
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
STRATA Skin Sciences, Inc. Q3 FY2022 Earnings Call
Revenue
$9.41M
▲ 22.1% YoY
Diluted EPS
$-0.30
Gross margin
61.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
STRATA Skin Sciences, Inc. Q2 FY2022 Earnings Call
Revenue
$9.11M
▲ 23.3% YoY
Diluted EPS
$-0.50
▼ 266.7% YoY
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
STRATA Skin Sciences, Inc. Q1 FY2022 Earnings Call
Revenue
$7.04M
▲ 20.8% YoY
Diluted EPS
$-0.70
Gross margin
58.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
STRATA Skin Sciences, Inc. Q4 FY2021 Earnings Call
Revenue
$9.06M*
▲ 34.8% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
STRATA Skin Sciences, Inc. Q3 FY2021 Earnings Call
Revenue
$7.71M
▲ 37.4% YoY
Diluted EPS
$-0.20
Gross margin
69.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
STRATA Skin Sciences, Inc. Q2 FY2021 Earnings Call
Revenue
$7.38M
▲ 83.2% YoY
Diluted EPS
$0.30
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
STRATA Skin Sciences, Inc. Q1 FY2021 Earnings Call
Revenue
$5.83M
▼ 13.4% YoY
Diluted EPS
$-0.70
Gross margin
63.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-12
STRATA Skin Sciences, Inc. Q4 FY2020 Earnings Call
Revenue
$6.72M*
▼ 24.5% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
STRATA Skin Sciences, Inc. Q3 FY2020 Earnings Call
Revenue
$5.61M
▼ 25% YoY
Diluted EPS
$-0.40
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-11
STRATA Skin Sciences, Inc. Q2 FY2020 Earnings Call
Revenue
$4.03M
▼ 47.8% YoY
Diluted EPS
$-0.50
Gross margin
48.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-20
STRATA Skin Sciences, Inc. Q1 FY2020 Earnings Call
Revenue
$6.73M
▼ 10.1% YoY
Diluted EPS
$-0.30
Gross margin
65.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 1051514 CUSIP 86272A305 Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)